(CNO) CNO Financial - Ratings and Ratios

CNO Financial Group, Inc. (NYSE:CNO) operates as a holding company for several insurance subsidiaries, specializing in health and life insurance products tailored for middle-income pre-retirees and retirees in the United States. Its product portfolio includes Medicare supplement insurance, long-term care coverage, individual life insurance policies, annuities, and supplemental health products like specified disease and accident insurance. The company distributes its products through multiple channels, including direct-to-consumer sales via phone, online, and in-person agents, as well as partnerships with employers and membership groups for voluntary benefits. CNO Financial markets its offerings under three primary brands: Bankers Life, Washington National, and Colonial Penn. The company, established in 1979 and headquartered in Carmel, Indiana, focuses on serving middle-income individuals, particularly those in or nearing retirement, with a range of financial protection and retirement planning solutions.

From a technical standpoint, CNOs stock has shown stability, with its 20-day average volume at 664,699 shares. The stock is currently trading at $39.58, slightly above its 20-day SMA of $38.78 but marginally below its 50-day SMA of $39.92. The 200-day SMA of $36.55 indicates a longer-term upward trend. The average true range (ATR) of 1.57 reflects moderate volatility. Fundamentally, CNOs market cap stands at $3.69 billion, with a trailing P/E of 9.84 and a forward P/E of 9.43, suggesting reasonable valuation. The price-to-book ratio of 1.48 and price-to-sales ratio of 0.83 further indicate a balanced valuation. The return on equity (RoE) of 16.17% highlights strong profitability relative to shareholder equity.

3-Month Forecast: Based on technical and fundamental data, CNOs stock is expected to remain stable with potential upside. The convergence of the 20-day and 50-day SMAs near current prices suggests a sideways trend in the near term, with support at $36.55 (200-day SMA). The moderate ATR of 1.57 indicates manageable volatility. Fundamentally, the companys focus on retirement and health products for middle-income Americans positions it well for steady demand. With a forward P/E of 9.43 and a P/B ratio of 1.48, the stock is attractively valued compared to historical levels. Expect CNO to trade in the range of $37 to $42 over the next three months, with potential for modest upside driven by consistent earnings and a strong balance sheet.